This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Evaluation

PHILIP H. TAYLOR, M.D.; LT. COL. JOHN A. MONCRIEF, MC; LT. COL. WALTER E. SWITZER, MC; MAJ. LAWRENCE R. ROSE, MC; LOUIS Q. PUGSLEY, M.D.

AMA Arch Surg. 1963;86(2):250-251.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The time-honored surgical principles of removal of necrotic tissue and early wound coverage remain important facets in the management of burned patients. Removal of the necrotic tissue can be accomplished by excision therapy, but adequate wound coverage, especially in large body-surface burns, presents a difficult problem. In the majority of these patients, donor skin is limited. Homograft skin, which usually produces a good temporary wound cover, is not always readily available. Many skin substitutes (e.g., synthetic substances and heterografts) have been tried and proved unsatisfactory.

Chardack, after laboratory and clinical evaluation, advocated the use of Ivalon surgical sponge (polyvinyl alcohol) as a temporary skin substitute or wound cover.^1,2 He has recently shown in humans that Ivalon adheres to granulating wound surfaces, producing an adequate temporary wound covering. After reviewing Chardack's work and after personal communication with him, evaluation of Ivalon as an adjunct to excision therapy was undertaken.

This . . . [Full Text PDF of this Article]

Author Affiliations
COLUMBUS, OHIO; USA; USA; USA; WASHINGTON, D.C.

From the U.S. Army Surgical Research Unit, Brooke Army Medical Center, Fort Sam Houston, Texas.

Footnotes
Submitted for publication June 27, 1962.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?